The US FDA granted the drug Breakthrough Therapy designation to Cidara Therapeutics’ its investigational influenza prophylactic, CD388, for the prevention of influenza A and B in high-risk adults and adolescents. #News #FluTherapy #CD388

seen from Malaysia
seen from United States

seen from Türkiye
seen from Türkiye
seen from Netherlands

seen from Türkiye
seen from Japan

seen from Türkiye

seen from Malaysia
seen from Germany

seen from Italy
seen from United States

seen from Malaysia
seen from China
seen from Georgia
seen from Türkiye
seen from China
seen from Australia

seen from Malaysia

seen from Malaysia
The US FDA granted the drug Breakthrough Therapy designation to Cidara Therapeutics’ its investigational influenza prophylactic, CD388, for the prevention of influenza A and B in high-risk adults and adolescents. #News #FluTherapy #CD388

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Cidara Therapeutics secures up to $339M from BARDA to expand U.S. manufacturing and clinical development of CD388, its long-acting, non-vaccine influenza preventative designed to offer broad protection against all flu strains. #News #BARDA #InfluenzaPrevention #CD388 #Biotech #PandemicPreparedness